Morgan Stanley Elanco Animal Health Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Morgan Stanley holds 4,344,714 shares of ELAN stock, worth $51.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,344,714

Previous 3,429,052 26.7%

Holding current value

$51.6 Million

Previous $49.5 Million 28.9%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.85 - $15.47 $10.9 Million - $14.2 Million	915,662 Added 26.7%	4,344,714 $63.8 Million
Q2 2024 Oct 17, 2024	SELL	$12.93 - $18.45 $16.8 Million - $23.9 Million	-1,297,235 Reduced 27.45%	3,429,052 $49.5 Million
Q2 2024 Aug 14, 2024	SELL	$12.93 - $18.45 $16.8 Million - $23.9 Million	-1,297,235 Reduced 27.45%	3,429,052 $49.5 Million
Q1 2024 Oct 17, 2024	BUY	$14.37 - $16.46 $18.6 Million - $21.4 Million	1,297,235 Added 37.83%	4,726,287 $76.9 Million
Q1 2024 Aug 16, 2024	SELL	$14.37 - $16.46 $18.8 Million - $21.6 Million	-1,311,705 Reduced 21.72%	4,726,287 $76.9 Million
Q1 2024 May 15, 2024	SELL	$14.37 - $16.46 $18.8 Million - $21.6 Million	-1,311,705 Reduced 21.72%	4,726,287 $76.9 Million
Q4 2023 Aug 16, 2024	BUY	$8.6 - $14.94 $22.4 Million - $39 Million	2,608,940 Added 76.08%	6,037,992 $90 Million
Q4 2023 Feb 13, 2024	BUY	$8.6 - $14.94 $16.2 Million - $28.2 Million	1,889,187 Added 45.54%	6,037,992 $90 Million
Q3 2023 Nov 15, 2023	BUY	$9.81 - $12.62 $2.82 Million - $3.63 Million	287,808 Added 7.45%	4,148,805 $46.6 Million
Q2 2023 Aug 14, 2023	BUY	$8.08 - $10.37 $2.16 Million - $2.78 Million	267,729 Added 7.45%	3,860,997 $38.8 Million
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $1.57 Million - $2.6 Million	178,374 Added 5.22%	3,593,268 $33.8 Million
Q4 2022 Feb 14, 2023	BUY	$11.49 - $13.65 $4.1 Million - $4.87 Million	356,423 Added 11.65%	3,414,894 $41.7 Million
Q3 2022 Nov 14, 2022	SELL	$12.41 - $32.42 $35.4 Million - $92.5 Million	-2,852,123 Reduced 48.25%	3,058,471 $38 Million
Q2 2022 Oct 27, 2022	BUY	$19.63 - $26.62 $49.5 Million - $67.1 Million	2,520,344 Added 74.34%	5,910,594 $116 Million
Q2 2022 Aug 15, 2022	BUY	$19.63 - $26.62 $49.5 Million - $67.1 Million	2,520,344 Added 74.34%	5,910,594 $116 Million
Q1 2022 Oct 27, 2022	SELL	$24.65 - $29.0 $62.1 Million - $73.1 Million	-2,520,344 Reduced 42.64%	3,390,250 $88.5 Million
Q1 2022 May 13, 2022	BUY	$24.65 - $29.0 $22.9 Million - $26.9 Million	928,745 Added 37.73%	3,390,250 $88.5 Million
Q4 2021 Feb 14, 2022	BUY	$27.74 - $34.09 $2.32 Million - $2.85 Million	83,712 Added 3.52%	2,461,505 $69.9 Million
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $69.4 Million - $87.3 Million	2,377,793 New	2,377,793 $75.8 Million

Others Institutions Holding ELAN

# of Institutions

437

Shares Held

473M

Call Options Held

4.62M

Put Options Held

753K

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account